MedPath

Virtual Reality Hypnosis Versus Inhaled Nitrous Oxide in Anterior Shoulder Dislocation Reduction: an Open Multicenter Randomized Controlled Trial

Not Applicable
Recruiting
Conditions
Shoulder Dislocation
Interventions
Procedure: Virtual reality hypnosis
Registration Number
NCT05388942
Lead Sponsor
CHU de Reims
Brief Summary

Anterior shoulder dislocation (ASD) is a common situation in the emergency department (ED). Quick reductions lead to reduced mid and long term complications. No technique is superior to one another. Inhaled nitrous oxide can deal with pain reduction and anxiety but its efficacy is not optimal, with safety issues. Virtual reality hypnosis (VRH), by distracting patients from their pain, may lead to a better muscular relaxation and an easier ASD reduction.

Our first objective is to evaluate the clinical interest of VHR compared to nitrous oxide, in ASD reduction. Our second objective is to evaluate the safety of VRH in ASD reduction.

Patients over 18 years presenting an ASD \< 24 hours, will be illegible for enrollment in an open multicenter randomized controlled trial, conducted in the Great East Region in France.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
126
Inclusion Criteria
  • patients of 18 years and older
  • consulting the ED for a ASD < 24 hours
  • with or without history of ASD
  • with social insurance
Exclusion Criteria
  • non anterior shoulder dislocation
  • shoulder or facial fracture or multiple trauma patient
  • dementia, psychosis
  • uncontrolled epilepsy
  • visual or hearing issues
  • claustrophobia
  • vascular or nervous lesion of the dislocated arm
  • contraindication with the use of inhaled nitrous oxide

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Virtual reality hypnosis (VRH)Virtual reality hypnosis-
Nitrous oxide (NO)Nitrous oxide-
Primary Outcome Measures
NameTimeMethod
Reduction of ASD procedure timeDay 0
Secondary Outcome Measures
NameTimeMethod
Achievement of the reduction of ASD procedureDay 0
Per-procedure painDay 0

Visual analogue scale

Passage time in the EDDay 0
Patient satisfactionDay 0

Likert scale in 5 points

Adverse events when using HRVDay 0
Adverse events when using inhaled NODay 0

Trial Locations

Locations (1)

Damien JOLLY

🇫🇷

Reims, France

© Copyright 2025. All Rights Reserved by MedPath